semaglutide news november 28 2025 Wegovy maker Novo Nordisk makes major announcement Cardiovascular outcomes of semaglutide and

56 Excessive RSS can trigger a series of related diseases such as inflammation, cancer, and Alzheimer's disease

Some studies have suggested that TB 500 can actually make someone more likely to develop cancer, and that it can exacerbate cancer cells that are already present

This phenomenon, often called metabolic adaptation, has been observed in studies on dieting and weight loss

The study used data on more than 145,000 people treated with GLP-1 agonists, and almost 292,000 people treated with DPP4 inhibitors.The researchers followed up participants after a mean of 3.9 years for the GLP-1 group and 5.4 years for the DPP4 group

This transparency helps anesthesiologists adjust your care pathway and reduces the risk of unexpected medication interactions

Antioxidants preserve redox balance and inhibit c-Jun-Nterminal kinase pathway while improving insulin signaling in fat-fed rats: evidence for the role of oxidative stress on IRS-1 serine phosphorylation and IR